Refreshed just now
Congress enacted H.R. 8205, the ALS therapy access reauthorization act, which was signed into law as Public Law 119-138 on November 3, 2026.
Why it’s here: A federal bill reauthorizing ALS therapy access programs became public law, a direct US federal legislative action relevant to biotechnology policy.
Trace across the boardItem
Nov 2CongressCongress enacted H.R. 8205, the ALS therapy access reauthorization act, which was signed into law as Public Law 119-138 on November 3, 2026.H.R. 8205BiotechDetails1 linked
Connected
1 links- NewsPublic Law 119 - 60 - National Defense Authorization Act for Fiscal Year 2026 - PLAW-119publ60 | Content Details | GovInfoBoth involve Public Law 119-138